ClinicalTrials.gg
RecruitingNCT06593574Updated Oct 22, 2024

Safety and Effectiveness Evaluation of Spinal Laminectomy Robot

An interventional study of Robotic laminectomy and Traditional laminectomy in Lumbar Spinal Stenosis and Lumbar Disc Herniation, sponsored by Peking University Third Hospital. Recruiting at 3 sites in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-10-22.

Sponsored by Peking University Third Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Oct 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Spinal Stenosis by Peking University Third Hospital — 2 open to participants now, 2 under way, none of them phase 3. Spinal Stenosis · Peking University Third Hospital.

Started
2024
the only one that year
No phase
6 of 10
1 open now
Registered
10th of 10
by date

Among the 10 studies in Spinal Stenosis by Peking University Third Hospital, this one is the only one that started in 2024, is one of 6 with no phase, and was the 10th registered.

Spinal Stenosis

460 studies on the registry are indexed under Spinal Stenosis; 107 are open to participants now.

Browse Spinal Stenosis studies →

Open to participants now

2 of the 10 studies in Spinal Stenosis by Peking University Third Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 66 Spinal Stenosis studies recruiting now, 30 (45%) set no upper age limit and 9 (14%) stop at 75 or younger; 2 take children under 18; 6 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Spinal Stenosis by Peking University Third Hospital, or all of them as a file.
02

Study summary

The purpose of this clinical trial is to evaluate the effectiveness and safety of this spinal robot in assisting doctors to perform laminectomy in spinal surgery under the premise of ensuring the safety of the subjects and ensuring the scientific nature of the clinical trial.

Read the detailed description

This is a multicenter, randomized, blind evaluation, parallel-controlled, and superiority clinical trial. The objective of this study is to evaluate the effectiveness and safety of a spinal robot in assisting surgeons in laminectomy. The experiment included 3 centers with a total sample size of 70. The experimental group is the robot laminectomy group (RL group), and the control group is the manual laminectomy group (ML group). Laminectomy in the RL group is performed robotically, while laminectomy in the ML group is performed by the physician using an ultrasonic osteotome. The primary outcome measure is the accuracy of laminectomy. Secondary outcome measures included JOA score, VAS score, laminectomy success rate, laminectomy time per spinal segment, total laminectomy time, operative time, amount of surgical bleeding, number of X-ray exposures and total dose, and planned area excision rate. The evaluation was completed by comparing the outcomes between the two groups.

03

Conditions studied

  • Lumbar Spinal Stenosis
  • Lumbar Disc Herniation

Keywords

  • Spinal robot
  • Laminectomy
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18-80 years old (including 18 and 80 years old), regardless of gender;
  • Patients with complete clinical data, willing and able to sign ;
  • Patients with lumbar disc herniation, lumbar spinal stenosis, lumbar instability, lumbar spondylolisthesis, and lumbar fracture meet the indications for spinal laminectomy and undergoing open surgery;
  • Patients with lumbar disc herniation, lumbar spinal stenosis, or lumbar instability have one of the following:

    1. It was not effective after 3 months of conservative treatment
    2. Symptoms seriously affect the quality of life
    3. cauda equina nerve injury
  • Lumbar spondylolisthesis occurs in one of the following:

    1. Symptoms of II° and below slip were not relieved by non-surgical treatment
    2. Lumbar spondylolisthesis III° and above
    3. Symptoms of lumbar spinal stenosis
  • The TLISS score of lumbar spine fracture is greater than or equal to 4 points.

Exclusion criteria

Exclusion Criteria:

  • Patients who are not suitable for robot-assisted surgery;
  • Patients with existing implants in or near the vertebral body of the lesion;
  • Patients whose vertebral lamina bone tissue of the focal vertebra or adjacent vertebra has been removed;
  • Pregnant and lactating female patients;
  • the subject is unwilling or unable to restrict activities or follow medical advice;
  • Patients with infection near the focal area;
  • The patient is mentally incapable or unable to understand the requirements for participating in the study;
  • The patient is critically ill, the expected survival period is not more than 2 years, and it is difficult to make an accurate assessment of the effectiveness and safety of the device;
  • Patients with coagulation dysfunction;
  • Other researchers did not consider it suitable for admission.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Robotic laminectomy group

    The laminectomy is performed with the assistance of a robot

    Procedure: Robotic laminectomy

  • Active comparator
    Manual laminectomy group

    The laminectomy is performed by the surgeon without the assistance of a robot

    Procedure: Traditional laminectomy

Interventions

  • ProcedureRobotic laminectomy

    Surgical robots are used to assist with laminectomy

  • ProcedureTraditional laminectomy

    Instead of relying on a surgical robot, doctors perform the laminectomy themselves with an ultrasonic osteotome

06

What researchers measure

Primary outcomes

  1. Accuracy rate of laminectomy

    According to the classification criteria for the accuracy of laminectomy proposed by Zhuofu Li, grade A indicates that the pre-planned cutting lines are basically located in the actual cutting groove or that the maximum distance between them is \<1mm; Grade B indicates that the maximum distance between the pre-planned cutting line and the actual cutting groove is 1 to 2mm. Grade C indicates a maximum distance of \>2 mm between the two. Grades A and B are acceptable. The percentage of A+B in the total number of planned boundaries was counted as the accuracy rate of laminectomy.

    Time frame: Immediately after the intraoperative laminectomy procedure

Secondary outcomes

  1. Success rate of laminectomy

    After the laminectomy is complete, check whether the laminectomy can be successfully removed. Each cutting plane is evaluated individually.

    Time frame: Immediately after the intraoperative laminectomy procedure

  2. Improvement rate of Japanese Orthopaedic Society (JOA) Score

    The JOA score is a scoring system used to assess lumbar dysfunction. The lumbar JOA score includes subjective symptoms (9), clinical signs (6), limits of daily activities (14), and bladder function (-6 to 0) on a 29-point scale. The lower the score, the more significant the dysfunction. Improvement rate = \[(post-treatment score - pre-treatment score)/(29 - pre-treatment score)\] × 100%.

    Time frame: JOA scores were used to evaluate experimental and control subjects before and one month after surgery.

  3. Visual analogue scale (VAS)

    Visual analog scale, which indicates the degree of pain. The VAS score was used to evaluate the pain degree of the experimental group and control group.

    Time frame: Before and one month after the operation

  4. Laminectomy time per spinal segment

    Laminectomy time for a single spinal segment = total laminectomy time ÷ Number of spinal segments with laminectomy.

    Time frame: Immediately after surgery.

  5. Total laminectomy time

    The time from the start of laminectomy until the tool stops working is denoted as the total laminectomy time.

    Time frame: Immediately after surgery.

  6. Operative time

    From the time the skin is cut to the time the suture is finished.

    Time frame: Immediately after surgery.

  7. Amount of surgical bleeding

    Amount of surgical bleeding

    Time frame: Immediately after surgery.

07

Study locations

1 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Dec 2025, 14 months after the start.

Of 106 non-industry interventional studies with no phase under Spinal Stenosis, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 46. This study's planned 14 months is below that.

Counting every sponsor, half of 124 studies reached it within 30 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2024
First posted
Sep 19, 2024
StartActual
Oct 15, 2024
Primary completionEst.
Dec 30, 2025
CompletionEst.
Dec 30, 2025
Last update
Oct 22, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06593574
Collaborators
The Third Affiliated Hospital of Southern Medical University, The First Affiliated Hospital of Zhejiang Chinese Medical University
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Oct 15, 2024
Primary completion
Dec 30, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Oct 22, 2024

Study contacts

Weishi Li, M.D.
Contact
puh3liweishi@163.com
(+86010)62017691-7011
Zhuofu Li, M.D.
Contact
bjmulizhuofu@163.com
Weishi Li, M.D.
principal investigator · Peking University Third Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion